chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8:39 am-Patient brought into Covid Observation Area after reporting dizziness, nausea, "heavy head" and increased heart rate few minutes after receiving Pfizer Booster vaccination. Patient assisted to gurney, placed in Trendelenburg position. States she experienced similar sx after 1st dose, spoke to her PCP regarding nausea persisting for few days, Zofran prescribed and nausea relief noted with Zofran. Patient also reports having similar sx after 2nd dose, but "not as bad", sx occurred later that day,  took  Zofran with relief noted. Patient reports Blood sugar this morning 125, she had breakfast,  took her BP medication and a Claritin.  8:41 am- VS- BP 139/98, HR 85, RR 20, 02 SATs 98% RA  8:46 am- VS- BP 127/92, HR 93, RR 20, 02 SATs 98% RA  8:47- Attempted to raise head of bed to offer crackers, patient states "heavy head" feels worse with sitting up. Will continue to monitor.  8:54- VS: BP 125/85, HR 83, RR 20, 02 SATs 98% RA- Patient states heart rate feels normal, nausea and heavy head continues. Repositioned patient to supine, provided saltine crackers to help with nausea.   9:00 am- Patient repositioned to right side, dry heaving, spitting saliva. Reports feeling better afterwards and states stomach does not feel as "queasy".  9:19 am- VS- BP 110/79, HR 76, RR 20, 02 SATs RA- Patient reports feeling better lying on right side, states heart rate normal, "heavy head" feeling and nausea improving.   9:34 am- VS- BP 108/72, HR 76. RR 20, 02 SATs RA- Patient called her husband to pick her up.  9:50- pt sleeping  9:57 am- Orthostatic BP checks Sitting -BP 130/88, HR 77, RR 20  02 SATs 99%- reports nausea and dizziness with sitting up Standing- BP 138/94, HR 85 RR 20 02 SATs 98%- reports nausea and dizziness with standing  10:00 am- Road test- Patient ambulated several feet, with stand by assistance. Denies feeling as if she is going to faint. States she feels "dizzy" in her head, worse with turning. Patient states she will be able to ambulate at home and husband will be there to assist if needed.  10:08 am- Discharged home in stable condition, accompanied by husband who will drive her home. Patient has an in person appointment with her PCP tomorrow. Instructed to rest, take Zofran as directed,  if needed for nausea, and seek Emergent care  for any worsening symptoms. Patient and husband verbalized understanding. Provided with a work note by PA who is working in Covid Observation Area today.
10/01/2021 [3 days after vaccination]: Fever (T-max 103), cough, chills, nausea, vomiting, and nonbloody diarrhea. Denied headache, chest pain, shortness of breath, abdominal pain, dysuria, or abnormal rash. Patient had taken ibuprofen for fever prior to arrival to ED.
7 month infant given Decavac (Td) 0.5ml instead of ordered Fluzone pf 0.25ml. Had received Pediarix doses 11/30/06, 10/2/06 and 7/28/06. No known affects-reporting due to close proximity of Pediarix doses and adversed dosing.
This spontaneous report as received from a health care worker refers to an unspecified number of patients of unknown demographics. On an unknown date the patients were vaccinated with 1 dose of VARIVAX (Merck) and 1 dose of M-M-R II that were reconstituted with sterile diluent (dose and lot number unspecified) which was expired at the end of January 2015. It was confirmed that VARIVAX (Merck) and M-M-R II were not expired. No adverse effect was reported. No product quality complaint involved. Additional information has been requested.
About ~18h after the third COVID19 vaccine injection, I had a low fever accompanied by headache, and sore muscles all over my body.; About ~18h after the third COVID19 vaccine injection, I had a low fever accompanied by headache, and sore muscles all over my body.; About ~18h after the third COVID19 vaccine injection, I had a low fever accompanied by headache, and sore muscles all over my body.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Oct2021 17:00 (Lot number: 3203080) at the age of 31 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: None. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247), administration date: 27Jan2021, when the patient was 30 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247), administration date: 17Feb2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious), HEADACHE (non-serious), MYALGIA (non-serious) all with onset 30Oct2021, outcome "recovering" and all described as "About 18h after the third COVID19 vaccine injection, I had a low fever accompanied by headache, and sore muscles all over my body." The patient underwent the following laboratory tests and procedures: body temperature: (30Oct2021) low. Therapeutic measures were not taken as a result of pyrexia, headache, myalgia.  Additional Information: About 18 hours after the third COVID19 vaccine injection, Patient had a low fever accompanied by headache, and sore muscles all over body. Facility where the most recent COVID-19 vaccine was administered was pharmacy or drug store. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No list of any other medications the patient received within 2 weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, Patient has been tested for COVID-19 and result is negative. known allergies and other medical history did not reported.  No follow-up attempts are possible. No further information is expected.
The employee received the vaccine on 12/17 at 0922. On 12/18 at 0200, he developed severe headache. At 0800, he started vomiting and had nausea until the evening. After the nausea/vomiting stopped, he took medications for headache. All symptoms were gone by 12/20 at 0200.
RECEIVED 2.5ML OF THE JANSSEN COVID-19 VACCINE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 33 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, and expiry: 07-MAR-2022) 2.5 ml, administered on 21-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-NOV-2021, the patient experienced received 2.5ml of the janssen covid-19 vaccine. On 21-NOV-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the received 2.5ml of the janssen covid-19 vaccine and off label use was not reported. This report was non-serious.
Syptoms started about 4 years ago and become more and more noticeable and more prevelant over time.  Syptoms are unlike patient has acted or felt normally.  Muscular twitching, dry red eyes, joint soreness, tendonitis, extended muscle soreness, tendons pop throughout the body at joints, confusion, major short term memory loss, lost sense of direction (physically), no motivation/lack of creativity, chronic fatugue, difficulty concentrating, difficulty learning new things, depression for no reason, anxiety (social and physical), restlessness, insomnia, destructive behavior (excessive drinking, fighting), moodiness, loss of libido, abdominal pains, pain underneath skin, cold sores, mucus build up in throat (constant for years), sore throat, swollen lymph nodes in neck and arm pits, bad headaches, weight loss (varying 10-20 lbs), ringing in ears, loss of balance, among other symptoms, these are all constant.
This spontaneous report as received from a physician refers to a female patient of unknown age. Concurrent conditions and medical history were not reported. The pediatrician reported that, on an unknown date, the mother overseas, who did not know that was pregnant, was inadvertently vaccinated with a dose of MMR II (Lot number, expiration date, route and dose were not reported). Concomitant medication were not reported. Additional information has been requested.
pt recv vax 28MAY96 & in 1996 pt exp hives;pt hives persisted @ the time of the report;
Client reported of experiencing heavy chest, rashes swelling throat 1 1/2 hour after vaccination, went to E.R and received BENADRYL/Epinephrine. Released at about 8 PM. Completely resolved. 3/24/09-records received for ED visit 3/16/09-impression:allergic reaction, minor, suspect secondary to injections. Presented to ED with C/O feeling tired and lightheaded one hour after receiving vaccines. Felt chest heaviness, voice feels slightly hoarse, itchy all over and face if tingly.
COVID-19 I experienced nasal congestion, fever of 103.00; body aches. I was prescribed PAXLOVID for my symptoms.
Very sleepy, slept most of the day. Had chills and fever of 102. Injection site was very sore. Blood sugar levels were very high (over 300) and did seem to respond to more insulin.
Patient began experiencing flushing and tingling sensation in throat/lips about 30 minutes after receiving 2nd dose of COVID vaccine.  Patient felt as though throat may have been closing so he administered an epi pen to himself. As no immediate relief patient administered a second epi pen which provided relief. Approximately one hour after vaccination patient felt back to normal and chose to leave the clinic with instructions to report to emergency room if symptoms began to return.
been bleeding since I get the shot; felt like peeing and blood start pouring out; My left leg felt like it was coming apart,other staff is coming from my body; This spontaneous case was reported by a consumer and describes the occurrence of GENITAL HAEMORRHAGE (been bleeding since I get the shot) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GENITAL HAEMORRHAGE (been bleeding since I get the shot) (seriousness criterion medically significant), URINARY INCONTINENCE (felt like peeing and blood start pouring out) and PAIN IN EXTREMITY (My left leg felt like it was coming apart,other staff is coming from my body). At the time of the report, GENITAL HAEMORRHAGE (been bleeding since I get the shot), URINARY INCONTINENCE (felt like peeing and blood start pouring out) and PAIN IN EXTREMITY (My left leg felt like it was coming apart,other staff is coming from my body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for pain in extremity included Tylenol.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-163847 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Fever  that typically stayed around 100.5; felt very weak; A little more tired than normal; Flu like symotoms; A report was received from a physician concerning a 60-year old, female patient who was participating in the mRNA-1273 a Program and experienced fever that typically stayed around 100.5, felt very weak, flu-like symptoms, and more tired than normal.   The patient's medical history, as provided by the reporter, included anxiety and COVID. Concomitant medications reported included fluoxetine.   On 23 Dec 2020, approximately 12 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (BATCH #025J202) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 24 Dec 2020, approximately 12 hours following vaccine administration, around 6 or 7 am, the patient began to experience "flu-like symptoms". She reported feeling a little more tired than normal, felt very weak, and had a fever staying around 100.5 °F. She took her temperature every few hours from 24 Dec 2020 to 25 Dec 2020, with the highest temperature being 101°F. The patient reported laying around for 48 hours and felt better. Treatment for the event included Tylenol and an unspecified non-steroidal anti-inflammatory drug (NSAID).   Action taken with mRNA-1273 in response to the events was not reported.  The events, fever that typically stayed around 100.5, was considered resolved on 25 Dec 2020. The events, felt very weak, flu-like symptoms, and more tired than normal, were considered resolved on 26 Dec 2020.   The reporter did not provide an assessment for the events, fever that typically stayed around 100.5, felt very weak, flu-like symptoms, and more tired than normal.; Reporter's Comments: This case concerns a 60-year old, female patient with medical history of anxiety and COVID, who experienced NS, expected events of pyrexia and fatigue and unexpected events of asthenia and influenza-like symptoms. The events occurred 7 hours after the administration of mRNA-1273 (BATCH #025J202). The patient reported laying around for 48 hours and felt better. Treatment for the event included Tylenol and an unspecified non-steroidal anti-inflammatory drug (NSAID). Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Hospital Principal Problem (Discharge Diagnoses): Acute renal failure, unspecified acute renal failure type (CMS/HCC)  ARDS Fungemia Bacteremia Acute renal failure requiring CRRT
Information has been received from  a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 09-APR-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1" sdv" (Lot No. K001631, exp. 06-NOV-2016) (dose and site not reported). On an unspecified date, the GARDASIL vaccine had a temperature excursion of 64 hours. The lowest recorded temperature was 34 (1.111111111 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
INAPPROPRIATE ROUTE OF VACCINE ADMINISTRATION; OFF LABEL USE; CHILLS; SWEATS; RUNNY NOSE; MUSCLE ACHES; FEVER; HEADACHE; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 51 year old white not Hispanic or Latino female. The patient's weight was 158 (unit not reported) and height was 160 centimeters. The patient's concurrent conditions included non-smoker, one drink per week, and seasonal allergies, and other pre-existing medical conditions included the patient did not have any drug abuse/illicit drug use. The patient received Covid-19 vaccine ad26.cov2.s by intravenous route (inappropriate route of vaccine administration and off label use) (batch number: 1805022 expiry: 25/MAY/2021) dose was not reported, administered on 06-Mar-2021. Concomitant medications included vitamins and supplements for good health. On 06-MAR-2021, the patient had experienced chills, sweats, fever, headache, nausea, fatigue, runny nose and muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, sweats, fever, headache, and nausea on 08-MAR-2021, was recovering from fatigue, and runny nose, had not recovered from muscle aches, and the outcome of inappropriate route of vaccine administration and off label use was not reported. This report was non-serious.  Additional follow up information received on 16-Mar-2021.The following information was updated and incorporated into the case: medical history, demographics, concomitant medication, route of administration for suspect product, lot number expiry date, events (inappropriate route of vaccine administration and off label use) and outcome (recovering from fatigue, and runny nose, had not recovered from muscle ache) was updated; Sender's Comments: V1:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
After the patient received the second dose of the Moderna vaccine, he experienced Bell face. After two days time, he was okay, and was not experiencing any other symptoms.
Rash of both hands  (primary encounter diagnosis), Sore mouth, Shortness of breath. Appears to be experiencing an immune reaction to her first covid-19 vaccine, and this is presenting in a rather odd fashion.
Pt recvd DTP/HIB on 20MAY92 & on 22MAY92 devel fever & rash; appeared 25MAY92;
According to father @ 6PM 27DEC90 pt had a fever. Did not take temp but said skin felt hot did give Tylenol but did not give any fluids. Developed diarrhea & vomiting that evening. 30DEC90 dad stated pt passed out; to ER via ambo
CHILLS, FEVER (UP TO 103) ACHES, WEAK LEGS, RASH ON RIGHT LEG, TOOK TYLENOL FOR FEVER, STILL ACHY BUT IMPROVING
Patient reported to the pharmacy for dose 2 of her of Pfizer Covid vaccine, she reported symptoms of throat constriction, malaise, cranial pressure and generalized itching. Patient appeared clammy, flushed, and confused. Patient was given 2 doses of Epi over 10-15 minutes and EMS was called but she refused transport to hospital due to financial issues.
Mom called to report that patient was experiencing numbness and tingling in her left arm/fingers after her flu shot.
Vaccinated 1510. Observed until 1530.  at 1540 it was reported that she had chest tightness. no trouble breathing but substernal chest pain 8/10. Vital signs- Temp-97.9 Pulse-95 BP- 162/100 Resp- 22 oxygen saturation- 95 @ room air. 1600- transported to ER for evaluation and treatment.
pt recvd vax & returned 2PM w/case of hives on neck, chest & abdo; MD dx allergic uticaria; MD prescribed DPH until rash
Supraclavicular adenopathy in L arm.  Developed 6 days after injection.
Slight headache right after continued for about 24 hrs 3hrs later nausea, chills, sweating, very cold & shortness of breath. That all went on all night about 9PM my hands were very swollen. My ring was hurting me. Also the site of the injection was very tender to the touch. Swelling went down by morning but nausea, chills & shortness of breath lasted about 24 hours.
terribly sick; no energy, completely weak; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (terribly sick), ASTHENIA (no energy, completely weak), CHILLS (chills) and HEADACHE (headache) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 23-Feb-2021, the patient experienced ILLNESS (terribly sick), ASTHENIA (no energy, completely weak), CHILLS (chills) and HEADACHE (headache). At the time of the report, ILLNESS (terribly sick), ASTHENIA (no energy, completely weak), CHILLS (chills) and HEADACHE (headache) outcome was unknown.            No laboratory data is provided. No concomitant medications.
Initial information received on 14-Sep-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves female patient (between the ages of 50 and 64) who experienced local reaction two years in a row/ swelling on the upper part of her arm so bad that she couldnt put her arm all the way down, while she received vaccine FLUZONE QUADRIVALENT. The patients past medical history, concomitant medication and family history were not provided. On an unknown date, the patient received injection of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number, expiry date not reported via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious couldnt put her arm all the way down (injected limb mobility decreased) with unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE. On an unknown date, the patient developed a non-serious local reaction/swelling on the upper part of her arm (vaccination site swelling) with unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE. This would last two weeks. Relevant tests were not reported. Final diagnosis was local reaction/swelling on the upper part of her arm and couldnt put her arm all the  way down. It was not reported if the patient received a corrective treatment. The outcome of the event reported as unknown. List of documents held by sender- none.
Developed mild joint pain on 3/19/21 in various joints throughout my body. Pain became increasingly uncomfortable. Saw primary provider on 4/14/21. Numerous blood tests run. Referred to Rheumatology and was seen on 5/20/21. DX : Polyarthritis/ Reactive. Stared on Naproxen 500mg 2X daily.  Joint pain improved .Admitted to hospital on 7/20/2021 in acute renal failure.
Nine days after vaccine was administered he developed a fever, three days later his fever spiked to 104 and he developed a measle like rash on face, trunk, and arms.  We did visit the physician and he was diagnosed as having a measle reaction to the MMR vaccine.  Treatment consisted of control of fever and fluids, and nothing placed on rash.
Initial report received from a health care professional on 28 October 2013. A 59-year-old male patient whose medical history and concomitant medication were not reported, received a dose of  FLUZONE ID (lot number: UT4720AA, expiry date: unknown) intradermal route on 27 September 2013. Patients had a red area at injection site after receiving vaccine on 27 October 2013. The event was not recovered. Patient received had several flu vaccines also last year. List of documents held by sender: none
I was fine from 10am until 3:30pm on the day of injection. I started to feel feverish and chills at 3:30 and it progressed into a 99.2 fever with all over body aches and a headache and chills. I took alkasletzer cold medicine with Tylenol in it to help with the fever. It got the symptoms down where I could move and stood in the hot shower for 30 minutes to help warm me up. I felt slightly better and still had fever symptoms and severe body aches. I started feeling unable to move due to the fever symptoms again around 9pm and took 2 extra strength Tylenol that eventually worked and I had some nausea with that. I hadn?t been able to eat because of the symptoms and the nausea could have been from taking meds on an empty stomach. I finally felt able to eat around 10pm and had some food and went to bed. I could barley sleep all night and was tossing and turning due to fever. My nose started to get runny around 10pm before I went to bed. I woke up the next day and still had the fever symptoms, body aches and the worst headache I have ever had, a 10 on the pain scale. I took another 2 extra strength Tylenol and went to sleep for 2 hours. I woke up and could tell the fever had broken and my head was still in pretty severe pain- about a 7 on the pain scale.  I was incredibly fatigued the entire day and felt hot and cold throughout the day. I was incredibly weak and needed a lot of rest. I still didn?t sleep well through the night and woke up friday feeling fatigued. I expended some energy in the am at the dog park and had to sleep for 3 hours during the day which is atypical for me. I woke up Saturday morning (today) still feeling a headache and exhaustion. I will see how the rest of the day goes and am hoping to feel better and don?t know when the symptoms will stop.